Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $639.54 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $330.37 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $264.18 | 2 | $0 (2023) |
| PFIZER INC. | $44.99 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.93 | 2 | Merck Sharp & Dohme LLC ($38.93) |
| 2023 | $349.33 | 6 | Janssen Biotech, Inc. ($264.18) |
| 2022 | $206.29 | 5 | Merck Sharp & Dohme LLC ($206.29) |
| 2021 | $44.99 | 2 | PFIZER INC. ($44.99) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2023 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 02/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $114.18 | General |
| Category: Oncology | ||||||
| 12/13/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2022 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $112.04 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 278 | 289 | $94,306 | $22,000 |
| 2022 | 4 | 297 | 304 | $92,372 | $20,607 |
| 2021 | 4 | 399 | 425 | $106,090 | $24,240 |
| 2020 | 5 | 350 | 381 | $85,850 | $19,368 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 86 | 91 | $44,740 | $10,314 | 23.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 93 | 98 | $32,646 | $7,455 | 22.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 88 | 89 | $15,629 | $4,005 | 25.6% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 11 | 11 | $1,291 | $225.60 | 17.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 110 | 112 | $37,309 | $8,567 | 23.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 76 | 77 | $37,857 | $8,406 | 22.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 93 | 96 | $16,859 | $3,542 | 21.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 18 | 19 | $346.94 | $92.54 | 26.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 89 | 92 | $45,232 | $10,572 | 23.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 116 | 122 | $40,641 | $9,013 | 22.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 98 | 104 | $18,263 | $4,119 | 22.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 96 | 107 | $1,954 | $536.50 | 27.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 64 | 70 | $34,416 | $7,723 | 22.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 76 | 78 | $25,983 | $5,836 | 22.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 116 | 124 | $21,776 | $4,919 | 22.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 77 | 92 | $1,680 | $505.25 | 30.1% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 17 | 17 | $1,995 | $384.35 | 19.3% |
About Michael White, PA-C
Michael White, PA-C is a Physician Assistant healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124157540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael White, PA-C has received a total of $639.54 in payments from pharmaceutical and medical device companies, with $38.93 received in 2024. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($639.54).
As a Medicare-enrolled provider, White has provided services to 1,324 Medicare beneficiaries, totaling 1,399 services with total Medicare billing of $86,215. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Weslaco, TX
- Active Since 03/02/2007
- Last Updated 07/08/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1124157540
Products in Payments
- ERLEADA (Drug) $264.18
- KEYTRUDA (Biological) $186.24
- LYNPARZA (Biological) $144.13
- XTANDI (Drug) $44.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Weslaco
Christa Palmer, Pa, PA
Physician Assistant — Payments: $3,930
Mr. Jose Ortega, Pa, PA
Physician Assistant — Payments: $1,605
Melissa Cantu-Garza, Pa, PA
Physician Assistant — Payments: $1,322
Mrs. Jessica Longoria, Pa-C, PA-C
Physician Assistant — Payments: $1,180
Paola Lopez, Pa, PA
Physician Assistant — Payments: $814.19
Tania Fabian-Navarrete
Physician Assistant — Payments: $644.27